Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Doernberg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JAMA Internal Medicine|December 8, 2025
Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments ActHarry Doernberg, Joshua D Wallach, Molly M Jeffery, et al.
Oncotarget|January 7, 2020
ISG15 induction is required during L1-mediated colon cancer progression and metastasisSanith Cheriyamundath, Sayon Basu, Gal Haase, et al.
BMJ Medicine|February 14, 2024
Published research on the human health implications of climate change between 2012 and 2021: cross sectional studyVictoria L Bartlett, Harry Doernberg, Maryam Mooghali, et al.
JAMA|April 22, 2024
Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease TreatmentsJoshua D Wallach, Samuel Yoon, Harry Doernberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JAMA Internal Medicine|December 8, 2025
Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments ActHarry Doernberg, Joshua D Wallach, Molly M Jeffery, et al.
Oncotarget|January 7, 2020
ISG15 induction is required during L1-mediated colon cancer progression and metastasisSanith Cheriyamundath, Sayon Basu, Gal Haase, et al.
BMJ Medicine|February 14, 2024
Published research on the human health implications of climate change between 2012 and 2021: cross sectional studyVictoria L Bartlett, Harry Doernberg, Maryam Mooghali, et al.
JAMA|April 22, 2024
Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease TreatmentsJoshua D Wallach, Samuel Yoon, Harry Doernberg, et al.
Pageof 1